Randomized trial comparing natural and synthetic surfactant: Increased infection rate after natural surfactant?

Acta Paediatrica, International Journal of Paediatrics

Volumn 89, Issue 5, 2000, Pages 510-512

  Speer, C P ^a   Robertson, B ^b   Halliday, H L ^c  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; C REACTIVE PROTEIN; CYTOKINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; HEXADECANOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUNG SURFACTANT EXTRACT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN D; TYLOXAPOL;

BACTERICIDAL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; HOST RESISTANCE; HUMAN; INFANT; INFECTION RATE; LEUKOPENIA; LUNG ALVEOLUS SURFACE TENSION; LUNG INFECTION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NONHUMAN; NOTE; PHAGOCYTOSIS; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS;

BIOLOGICAL PRODUCTS; DRUG COMBINATIONS; FATTY ALCOHOLS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PHOSPHOLIPIDS; PHOSPHORYLCHOLINE; POLYETHYLENE GLYCOLS; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK; SEPSIS;

EID: 0033871696     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2000.tb00328.x     Document Type: Note

References (30)

1. Randomized trial comparing natural and synthetic surfactant: Increased infection rate after natural surfactant?
2. Surfactant therapy in the newborn
3. Oxygen radicals, cytokines, adhesion molecules and lung injury in neonates
4. Biophysical aspects in the design Of a therapeutic surfactant
5. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants
6. Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits
7. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient lambs
8. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment
9. Changes in exogenous surfactant in ventilated preterm lamb lungs
10. Natural Vs synthetic surfactants in neonatal respiratory distress syndrome
11. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome
12. Immunomodulatory functions of surfactant
13. Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf)
14. Modified natural porcine surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytes
15. Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia
16. Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits
17. Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant
18. Lung surfactant suppresses oxygen-dependent bactericidal functions of human blood monocytes by inhibiting the assembly of the NADPH oxidase
19. Pulmonary suffactant lipids inhibit prostanoid production of guinea pig alveolar macrophages
20. Regulation of human alveolar macrophage inflammatory cytokines by tyloxapol: A component of the synthetic surfactant Exosurf
21. Inhibitory effect of porcine surfactant on the respiratory burst oxidase in human neutrophils. Attenuation of p47phox and p67phox membrane translocation as the mechanism
22. Pulmonary surfactant inhibits interleukin-2-induced proliferation and the generation of lymphokine-activated killer cells
23. Surfactant downregulates synthesis of DANN and inflammatory mediators in normal human lung fibroblasts
24. Surfactant suppresses NF-KB activation in human monocytic cells
25. Natural porcine surfactant (Curosurf®) down-regulates mRNA of tumor necrosis factor-α and TNF-α type II receptor in lipopolysaccharide-stimulated monocytes
26. Tracheal surfactant protein-A following treatment with Curosurf
27. Opsonic activities of surfactant proteins A and D in phagocytosis of Gram-negative bacteria by alveolar macrophages
28. Potential role of surfactant proteins A and D in innate lung defense against pathogens
29. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome
30. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome